The Impact of Nutrigenomics on Metabolic Health

The Promise and Challenges of Microbiome Therapeutics

European Commission Grants AbbVie Conditional Marketing Authorization for Epcoritamab to Treat Relapsed/Refractory Follicular Lymphoma in Adults

BerGenBio Partners with Tempus to Advance Development in STK11-Mutant Non-Small Cell Lung Cancer

Danaher Acquires Swiss Life Sciences Software Firm Genedata

EMA Validates Type II Variation Application for ENHERTU® in HER2 Low and Ultralow Metastatic Breast Cancer After Prior Endocrine Therapy

REGENXBIO Reports Encouraging Interim Results from Phase II AAVIATE® Trial of ABBV-RGX-314 for Wet AMD Treatment via Suprachoroidal Delivery

Imfinzi Approved in the US for Pre- and Post-Surgery Treatment of Resectable Non-Small Cell Lung Cancer

"LEQEMBI® (Lecanemab) Receives Approval for Alzheimer's Disease Treatment in the United Arab Emirates"

Universal DX Completes Series B Round to Launch Clinical Trial for Colorectal Cancer Screening Test

Sophia Genetics' DDM Platform Achieves CE Marking

Qure.ai Earns 12th Indian Patent for Advanced Lung Abnormality Detection System

Enhertu Receives Approval in China for HER2-Positive Gastric and Gastroesophageal Junction Cancer

Biocartis Names Dr. W. Michael Korn as Chief Medical and Scientific Officer, Renowned Precision Oncology Expert

RNT Medical College Udaipur to Launch India's First Sickle Cell Wellness Hub